Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

PTIX

Protagenic Therapeutics (PTIX)

Protagenic Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PTIX
DatumZeitQuelleÜberschriftSymbolFirma
14/02/202420h29Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PTIXProtagenic Therapeutics Inc
15/12/202321h50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTIXProtagenic Therapeutics Inc
29/11/202323h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTIXProtagenic Therapeutics Inc
14/11/202322h02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PTIXProtagenic Therapeutics Inc
02/11/202321h29Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PTIXProtagenic Therapeutics Inc
13/10/202318h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTIXProtagenic Therapeutics Inc
14/08/202321h29Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PTIXProtagenic Therapeutics Inc
17/04/202320h44Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:PTIXProtagenic Therapeutics Inc
22/03/202318h29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIXProtagenic Therapeutics Inc
14/11/202220h20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTIXProtagenic Therapeutics Inc
12/10/202212h01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTIXProtagenic Therapeutics Inc
11/08/202222h07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTIXProtagenic Therapeutics Inc
13/05/202212h36Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTIXProtagenic Therapeutics Inc
08/03/202222h03Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PTIXProtagenic Therapeutics Inc
15/02/202212h17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PTIXProtagenic Therapeutics Inc
04/02/202222h33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PTIXProtagenic Therapeutics Inc
23/11/202114h45TipRanksProtagenic Therapeutics (PTIX) Initiated with a Buy at Maxim GroupNASDAQ:PTIXProtagenic Therapeutics Inc
16/11/202115h58GlobeNewswire Inc.Protagenic Therapeutics Announces Third Quarter 2021 Results and Business UpdateNASDAQ:PTIXProtagenic Therapeutics Inc
15/11/202122h55Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTIXProtagenic Therapeutics Inc
05/10/202123h26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIXProtagenic Therapeutics Inc
01/10/202123h20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIXProtagenic Therapeutics Inc
10/09/202122h57Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:PTIXProtagenic Therapeutics Inc
30/08/202115h15GlobeNewswire Inc.Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ETNASDAQ:PTIXProtagenic Therapeutics Inc
19/08/202112h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIXProtagenic Therapeutics Inc
17/08/202113h45GlobeNewswire Inc.Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business UpdateNASDAQ:PTIXProtagenic Therapeutics Inc
16/08/202123h04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTIXProtagenic Therapeutics Inc
13/08/202123h29Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PTIXProtagenic Therapeutics Inc
23/07/202122h21GlobeNewswire Inc.Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical TrialNASDAQ:PTIXProtagenic Therapeutics Inc
06/07/202112h17GlobeNewswire Inc.Protagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at 10:00 A...NASDAQ:PTIXProtagenic Therapeutics Inc
02/07/202122h50Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIXProtagenic Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PTIX